Episodes

SCOTUS has rejected use of race in higher education, which brings up a reflection on what we learned during the pandemic and the result of compounding generational discrimination. A new MDMA PTSD treatment is on the rise, while the health …

Vic Gatto and Marcus Whitney cover an array of trending topics including the Aledade capital raise, the letter from Senators Warren and Welch to Amazon regarding Amazon Clinic, the ASGE AI Task Force, and more.

Vic Gatto and Marcus Whitney are joined by special guest Aaron Gani from BehaVR, Inc. for a discussion on the Digital Therapeutics space. We're also covering the "hawkish" Fed pause, a sign of increasing patient volumes from UHG, and more.

Vic Gatto and Marcus Whitney discuss the Sequoia Capital split, the NEDA Chatbot mishap, Optum's bid for Amedisys, and more.

Vic Gatto and Marcus Whitney cover recent trending topics in healthcare including the Theranos scandal, CommonSpirit’s quarterly report, VC news from WSJ, the PCE index increase, and more.

Vic Gatto and Marcus Whitney explore the recent sale of Pear Therapeutics and what this situation means for the road ahead in the digital therapeutics space. Also included in the discussion is an in-depth look at a recent call to …

Vic Gatto and Marcus Whitney discuss recent developments in healthcare including details around the KKR/Envision bankruptcy situation, the debt ceiling crisis, advancements in AI tech and impact on healthcare, and more.

Emily Evans joins co-hosts Vic Gatto and Marcus Whitney for the discussion in Episode 2. Emily serves as the Health Policy Resident Expert at Hedgeye Risk Management, an independent research firm with a focus on all areas of the economy. …

Healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney dive into the history of Health:Further and the purpose of the relaunch. We’re also covering the rise of federal fund rates, market trends, new innovations, what...